JPMorgan Chase & Co. Reduces Major Shareholding in Spire Healthcare Group PLC

JPMorgan Chase & Co. has reduced its major shareholding in Spire Healthcare Group PLC, with its voting rights decreasing from 5.440% to 5.346% as of October 21, 2026. The firm now holds a total of 21,531,521 voting rights, comprising direct voting rights of 0.901% and indirect voting rights of 4.445% through cash-settled equity swaps.